CytRx Appoints Shanta Chawla, M.D. as Vice President, Clinical Development

Published January 16, 2014

CytRx Appoints Shanta Chawla, M.D. as Vice President, Clinical Development
LOS ANGELES, Jan 16, 2014 (BUSINESS WIRE) — CytRx Corporation (NASDAQ:CYTR) , a biopharmaceutical research and development company specializing in oncology, today announced the appointment of Shanta Chawla, M.D. as Vice President, Clinical … “In …
Read more on MarketWatch

Mass. General, Broad Institute, and Amgen will work to discover new drugs for …
While drugs developed over the last decade have led to some marked improvements in IBD treatment, the drugs are not always effective and can cause significant side effects in some patients. … Founded by MIT, Harvard and its affiliated hospitals, and …
Read more on Bioscience Technology

One Health Care Reformer's Plan To Fix Obamacare 'Disaster'
"The foundations and the intent of the Affordable Care Act are laudable," said Dr. Patrick Soon-Shiong, a Los Angeles-based surgeon and drug inventor-turned-entrepreneur. "The way it's being implemented is a disaster." On Monday … The platform also …
Read more on Huffington Post

drug abuse treatment – http://drugtreatmentcenterlosangeles.org/ http://maps.google.com/maps/place?q=drug+treatment+centers&hl=en&cid=5162435111732940936 Drug Treatment Center Los …